Jazz Pharmaceuticals Celebrates International Women’s Day
NORTHAMPTON, MA / ACCESSWIRE / March 20, 2024 / Jazz Pharmaceuticals
Originally published by Jazz Pharmaceuticals
To mark International Women's Day, JAWS (Jazz Association of Women Supporters), the affinity forum created to promote the advancement and impact of women globally in the innovative biotechnology industry, hosted Jenn Harper, the founder and CEO of Cheekbone Beauty Cosmetics for a fireside chat. This inspirational event focused on Ms. Harper's personal journey, her sustainable, socially conscious beauty brand and her mission to support Indigenous youth.
At Jazz, we are highly committed to creating a work environment where people can be their authentic selves and where we ensure our people practices promote diversity, equity, inclusion and belonging. Jazz efforts to support women are an ongoing commitment and our Corporate Sustainability and Social Impact strategy is aligned with the UN Sustainable Development Goals. Through our aspirational goals and initiatives, we seek to achieve gender parity globally at the Executive Director and above leadership level to foster increased gender representation in leadership roles. Below is a snapshot of our latest activities to demonstrate gender diversity and our support of women in the workforce.
- Renée Galá named President and Chief Operating Officer
- Liz Henderson named Sr. Vice President Technical Operations
- Jazz Italy Signs Code for Responsible Businesses in Support of Motherhood
- Neena Patil, Chief Legal Officer featured in PharmaVoice discussing her views on leadership, ESG and healthcare
- Heidi Manna, Chief People Officer speaks to the importance of company culture and JazzRemix
- France Gender Equality Index and Jazz Pharmaceuticals Ethical Standards
View additional multimedia and more ESG storytelling from Jazz Pharmaceuticals on 3blmedia.com.
Contact Info:
Spokesperson: Jazz Pharmaceuticals
Website: https://www.3blmedia.com/profiles/jazz-pharmaceuticals
Email: info@3blmedia.com
SOURCE: Jazz Pharmaceuticals
View the original press release on accesswire.com
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back